RPHM: reneopharma.com Expected earnings per share growth for next year

Public company logo of Reneo Pharmaceuticals (RPHM)

Reneo Pharmaceuticals (RPHM) minimizes downtime risks through US cGMP facilities and outsourced development. The projected net profit growth rate for n+1 exhibits volatility, where the 0.00 metric indicates the status of current expectations. Logistics are based on individual delivery to medical centers; however, technological stagnation and restructuring following failures with myopathies are temporarily hindering the release of new molecules.

Reneo Pharmaceuticals Inc. (RPHM): Net earnings per share change forecast for next year from 07/04/2022 to 10/07/2024

Analytical breakdowns and data insights for company Reneo Pharmaceuticals Inc. (RPHM)

- share price and consensus valuation forecast:
Fundamental company valuation:RPHM, reneopharma.com
Finished products of Reneo Pharmaceuticals, Inc.

The specifics of the Reneo Pharmaceuticals (RPHM) biotech model lie in fixed R&D costs and the potential for ultra-high margins when bringing orphan drugs to market. This indicator measures the expected percentage growth in earnings per share, reflecting the consolidated analyst forecast for business scalability, which allows for the assessment of future capitalization via this analyst EPS growth chart.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|ETON: Expected earnings per share trend next year|Net earnings per share growth forecast for next year kamada.com (KMDA)|Expected earnings per share growth for next year Fulcrum Therapeutics FULC|Earnings growth forecast for next year ABEO (Abeona Therapeutics, Inc.)|Earnings growth forecast for next year Mereo BioPharma MREO|PLX - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PLRX|Applied Therapeutics (APLT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Rein Therapeutics Inc (RNTX)|Net earnings per share growth forecast for next year Gelteq Limited|AYTU (Aytu BioPharma) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Chemomab Therapeutics Ltd (CMMB)|SRXH (SRx Health Solutions) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Polyrizon Ltd PLRZ|Expected earnings per share trend next year AEZS|CYTH: Expected earnings per share growth for next year|inozyme.com (INZY) - Expected earnings per share growth for next year|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year